Newton and colleagues uncovered a tumour-promoting role of proline in response to systemic host metabolic changes using an obesity-enhanced tumour model that combines RasV12 with the knockout of the negative regulator of Src, C-terminal src (RasV12csk−/−) raised on a high-sugar diet (HSD) [69]. Here, SRC is linked to neoplasm.